Abstract: The receptor killer cell lectin-like receptor G1 (KLRG1) is expressed on T and NK cells, which binds to ligands on epithelial and mesenchymal cells. The ligand for KLRG1 has been described to be E-cadherin, N-cadherin, and R-cadherin. The present disclosure relates to and results from the discovery and characterization of antibodies that bind the extracellular domain (ECD) of KLRG1 but do not interfere with its interaction with the ligands E-cadherin, N-cadherin, and R-cadherin. The antibodies described have been derived by mouse hybridoma technology, and can be humanized by grafting their complementary determining regions (CDRs) into a human framework. The antibodies described can be used as effective therapeutic agents. Various antibodies, or antigen-binding fragments of such antibodies, along with various therapeutic and/or diagnostic methods, among other features, are provided for in the present disclosure.

Abstract: The present invention generally relates to the field of treatment of fibroproliferative diseases and disorders and cancer. Embodiments of the present invention generally relate to compostions, methods and kits comprising an inhibitor of a portion of the N-terminal pro-fibrotic domain (PFD) of Aortic Carboxypeptidase-Like Protein (ACLP), and in some embodiments, in combination with an inhibitor of the discoidin (DS) domain of ACLP, for use in methods for the treatment of fibroproliferative diseases and cancer, and inhibition of ACLP-mediated activation of a member of the TGF? receptor superfamily.

Abstract: The invention relates generally to variant activatable antibodies that include a masking moiety (MM), a cleavable moiety (CM), and an antibody (AB) that specifically binds to epidermal growth factor receptor (EGFR), and to methods of making and using these variant anti-EGFR activatable antibodies in a variety of therapeutic, diagnostic and prophylactic indications.

Abstract: This invention provides chimeric antigen receptors (CARs) targeting human EphA3 and dual targeting CARs that bind to human EphA3 and to human mutant epidermal growth factor receptor variant III (EGFRvIII). This invention also relates to CAR-T cells comprising the provided CARs or the dual targeting CARs. Methods for treating a solid tumor cancer by administering the CARs are provided.

Abstract: Provided herein are IL10R binding molecules that bind to IL10Ra and IL10Rb and comprise an IL10Rb sdAb and an IL10Rb VHH antibody.

Abstract: Provided herein are methods of treating a subject with hyperammonemia or a urea cycle disorder. The methods comprise administering to a subject in need thereof a therapeutic amount of a glucagon signaling pathway inhibitor, such that ammonia levels are lowered or that amino acid metabolism enzymes are down-regulated, or a condition or disease characterized by hyperammonemia is mediated, or at least one symptom or complication associated with the condition or disease is alleviated or reduced in severity. The glucagon signaling pathway inhibitor can be a small molecule inhibitor of the signaling pathway, an antisense inhibitor of the signaling pathway, shRNA, siRNA, a GCG neutralizing monoclonal antibody, a GCGR antagonist, a peptide inhibitor of the signaling pathway, a DARPin, a Spiegelmer, an aptamer, engineered Fn type-III domains, etc. The therapeutic methods are useful for treating a human suffering from hyperammonemia or a urea cycle disorder.

Abstract: Described are novel antibody molecules that specifically bind to TNFR2 on a target cell and thereby agonize TNFR2, but that do not block the ligand TNF-? from binding to the TNFR2. Also described is the use of such antibody molecules in medicine, i.a, in treatment of cancer or chronic inflammatory diseases.

Abstract: The invention relates among others to antibodies comprising a first antigen-binding site that binds Erb B-2 and a second antigen-binding site that binds Erb B-3. The antibodies can typically reduce a ligand-induced receptor function of Erb B-3 on a Erb B-2 and Erb B-3 positive cell. Also described are method for the treatment and use of the antibodies in imaging and in the treatment of subjects having an Erb B-2, Erb B-3 or Erb B-2/3 positive tumor.

Abstract: Described herein are materials and methods for treating subjects having a HER-3 associated disease, by administering a first agent that binds to HER-3, in combination with a second agent that binds and/or inhibits another member of the HER family. The first and the second agent may be a biologic, such as an antigen-binding protein, or a small molecular tyrosine kinase inhibitor, for example.

Abstract: The present invention relates to antibodies, binding polypeptides, and scFvs specific for fibroblast activation protein (FAP) capable of cross reacting with canine, mouse, and human FAP.

Abstract: The disclosure provides antibodies that specifically bind human IDO and methods of use thereof. In some aspects, the disclosure is directed to methods of detecting IDO in a biological sample comprising contacting the biological sample with an antibody described herein.

Abstract: Disclosed is a method for improving affinity of an antibody for an antigen, comprising, in an unmodified antibody, improving affinity for an antigen as compared to the unmodified antibody, by changing 17th, 18th and 20th amino acid residues of a light chain defined by Kabat method to charged amino acid residues.

Abstract: The present invention generally relates to novel bispecific antigen binding molecules for T cell activation and re-direction to specific target 511cells. In addition, the present invention relates to polynucleotides encoding such bispecific antigen binding molecules, and vectors and host cells comprising such polynucleotides. The invention further relates to methods for producing the bispecific antigen binding molecules of the invention, and to methods of using these bispecific antigen binding molecules in the treatment of disease.

Abstract: Compounds for targeting and agents for imaging, prostate-specific membrane antigen (PSMA) are disclosed. Methods of synthesizing compounds and imaging agents, as well as methods for imaging PSMA are also disclosed. The imaging agents disclosed are suitable for PET and SPECT imaging.

Abstract: Synthetic peptides which have been shown to be FGF18 agonists are described. Topical compositions for decreasing, eliminating, or suppressing hair growth are disclosed herein. Methods for reducing hair growth, improving the appearance of skin, kits, and related cosmetic formulations are also provided herein.

Abstract: The present invention relates to natural or natural-like analogues of insect kinin neuropeptide [Hy]-RQKTVFSSWG-[NH2] (SEQ ID NO:2) having activity against insects, for example hemipteran, dipteran, lepidopteran and/or blattodean insects, such as aphids, moths and fruit flies, and their use as insect control agents (e.g. insecticides) and plant protection agents.

Abstract: A synthetic peptide sp2 has the amino acid sequence shown in SEQ ID No: 1. sp2 has obvious anti-tumor growth activity on xenograft tumours such as subcutaneous human pancreatic cancer, human cervical cancer, and human ovarian cancer in nude mice, with a dose-effect and time-effect relation; and has the effect of delaying metastasis and prolonging the survival time of nude mouse having in situ transplantation of human pancreatic cancer and lung adenocarcinoma. After the animals were given intravenous injection of sp2 at a dose of 2000 mg/kgBW, no toxicity reaction and death were observed. The applications of sp2 also include: (1) preventing and/or treating of tumor; (2) inhibiting proliferation and/or growth and/or invasion of tumor cells; (3) enhancing the anti-tumor immune response; (4) inducing tumor cell differentiation; (5) preparing anti-tumor drugs; (6) inhibiting tumor telomerase activity; and (7) regulating the tumor cell cycle.

Abstract: The present invention relates to crystalline forms of carbetocin, a method of their manufacture, and pharmaceutical compositions thereof.

Abstract: This invention relates generally to covalently crosslinked colloidal cellulose nanocrystals (xCNC) and methods of preparation and use thereof. The colloidal cellulose nanocrystals (CNCs) are covalently crosslinked in aqueous suspension to generate a network showing tunable physicochemical properties. The xCNC structures are tunable in terms of their physicochemical properties and arrangement within the hydrogel network. The covalent crosslinking of solitary sulfonated (—OSO3) CNCs can be accomplished without prior hydroxyl replacement or functionalization.

Abstract: A cellulose resin in which hydrogen atoms of hydroxy groups of cellulose are substituted with a long-chain component which is a linear aliphatic acyl group having 14 or more carbon atoms and a short-chain component which is at least one of an acyl group having 2 carbon atoms and an acyl group having 3 carbon atoms, wherein a nitrogen content in the cellulose resin is 300 ppm or more and 2000 ppm or less. To provide a cellulose resin excellent in mechanical properties and heat decomposition resistance.

Abstract: A process can be used for preparing polyether-modified polybutadienes. The process involves reacting at least one polybutadiene (A) with at least one epoxidizing reagent (B) to give at least one epoxy-functional polybutadiene (C). The at least one epoxy-functional polybutadiene (C) is then reacted with at least one hydroxy-functional compound (D) to give at least one hydroxy-functional polybutadiene (E). The at least one hydroxy-functional polybutadiene (E) is finally reacted with at least one epoxy-functional compound (F) to give at least one polyether-modified polybutadiene (G).

Abstract: A polymer may have a molecular mass of less than 8,000 g/mol and a polymolecularity index PI of less than 3, produced by free radical polymerization, in water, and at a temperature higher than 50° C., of at least one anionic monomer comprising at least one polymerizable olefinic unsaturation and at least one carboxylic acid function, in the presence of phosphorus with a degree of oxidation I, phosphorus with a degree of oxidation III and a radical-generating compound. Such polymers may be produced and use for grinding mineral matter, as a detergent agent, or as an anti-scaling agent.

Abstract: An isoprene-based polymer latex composition includes a chloroprene polymer latex (A) and an isoprene polymer latex (B), in which the chloroprene polymer has a z-average particle size of 180 nm or greater and smaller than 300 nm, and a tetrahydrofuran-insoluble fraction of 80 to 99% by mass; the chloroprene polymer latex (A) is (1) a copolymer latex of chloroprene (A 1) and 2,3-dichloro-1,3-butadiene (A-2-1), or (2) a copolymer latex of the above (A-1) and (A-2 1), and another monomer (A-2-2); and the copolymer is obtained by copolymerization in which the ratio of 2,3-dichloro-1,3-butadiene (A-2-1) is 5.0 to 30.0% by mass relative to the total amount of the monomer components chloroprene (A-1) and 2,3-dichloro-1,3-butadiene (A-2-1) of 100% by mass. The isoprene-based polymer latex composition's quality is maintained, and the properties after cross-linking of a molded product obtained by dipping a dipping former into the composition multiple times do not deteriorate.

Abstract: A process or apparatus for producing polyethylene with improved film thinning and handleability involves polymerizing high-pressure ethylene using an autoclave-type reactor in the presence of a polymerization initiator. The reaction zone of the reactor has at least two different temperature sections; the polymerization initiator and the ethylene are supplied to the upstream temperature section in the reaction zone and the ethylene is polymerized to generate polyethylene; unreacted ethylene and the polyethylene generated at the upstream temperature section in the reactor flow into the downstream temperature section in communication with the upstream temperature section, so that additional polyethylene is generated at the downstream temperature section. A difference (?T [° C.]) between a temperature (T1 [° C.]) of the temperature section positioned upstream and a temperature (T2 [° C.

Abstract: The disclosure relates to a polymerization process. The polymerization process comprises polymerizing an olefin monomer and a comonomer in the presence of a polymerization catalyst in a polymerization step conducted in a polymerization reactor in a solvent to produce a solution comprising a polymer of the olefin monomer and the comonomer. The polymerization process comprises withdrawing an exhaust stream of the solution from the polymerization reactor in a withdrawing step. The polymerization process comprises separating the exhaust stream to a first primary stream and a primary concentrated solution stream in a first primary separation step, wherein the first primary stream comprises hydrocarbons and polymer. The polymerization process comprises separating the first primary stream to a second primary stream and a third primary stream in a second primary separation step, wherein the second primary stream comprises dissolved polymer and the third primary stream comprises majority of the hydrocarbons.

Abstract: The present invention relates to a supported catalyst for propylene polymerization in which a first transition metal compound contributing to the production of crystalline polypropylene and a second transition metal compound contributing to the production of rubbery polypropylene are co-supported, and a method for producing a polypropylene resin using same. By using the supported catalyst, according to the present invention, it is possible to produce, by a single step of propylene polymerization, a polypropylene resin in which crystalline polypropylene and rubbery polypropylene are simultaneously formed.

Abstract: A curable composition that gives a cured product exhibiting a high refractive index and a surface without defects such as roughness or cracks, a cured product of the composition, and a compound that may be blended to the composition. A triazine compound is used as a curable component in a curable composition, the triazine compound having an optionally substituted quinolinyl group, an optionally substituted isoquinolinyl group, or an optionally substituted 2-substituted benzothiazolyl group and an aromatic-ring-containing group having a radically polymerizable group-containing group or an aromatic-ring-containing group having a cationically polymerizable group-containing group, each group bonded to the triazine ring via an amino group.

Abstract: The present invention provides high temperature performing, conductive thermosetting resin compositions.

Abstract: A method of forming a composite material includes photo-initiating a polymerization of a monomer in a pattern of interconnected units to form a polymer microlattice. Unpolymerized monomer is removed from the polymer microlattice. The polymer microlattice is coated with a metal. The metal-coated polymer microlattice is dispersed in a polymer matrix.

Abstract: A phase difference film composed of a resin C containing a copolymer P including a polymerization unit A and a polymerization unit B, the phase difference film including a lamellar phase separation structure that generates a structural birefringence, the phase separation structure including a phase (A) having the polymerization unit A as a main component and a phase (B) having the polymerization unit B as a main component, and the phase difference film satisfying the formulae (1A): f(A)>0.5 and (2):D(A)>D(B), or the formulae (1B): f(B)>0.5 and (2). f(A) represents a total weight ratio of the polymerization unit A in the copolymer P, f(B) represents a total weight ratio of the polymerization unit B in the copolymer P, D(A)=ReA(450)/ReA(550), D(B)=ReB(450)/ReB(550), and ReA(450), ReA(550), ReB(450) and ReB(550) are as defined in the description.

Abstract: Provided is an oxygen-curable silicone composition that cures at room temperature, the reaction being triggered by oxygen in the atmosphere, without requiring heat or UV irradiation at the time of use, and exhibits good mechanical strength after curing. A composition including (A) an organopolysiloxane (1) (R1 represents an alkyl group or the like but has at least one acryloyloxy group or the like in the molecule, R2 represents an oxygen atom or the like, and m and n represent numbers that satisfy 1?m+n?1,000.), (B) a silicone resin including (a) a unit of formula (2), (b) an R13SiO1/2 unit, and (c) an SiO4/2 unit, the molar ratio of [(a)+(b)]/(c) being 0.4-1.2, and the silicone resin having 0.005 mol/100 g or more Si—OH groups (R1 and R2 are the same as above. R3 represents an acryloyloxyalkyl group or the like, p represents 0-10, and 1 represents a number that satisfies 1-3.), and (C) an organoborane complex (3) (R4-R6 represent hydrocarbon groups.).

Abstract: A conjugated diene copolymer has a covalent bond reversibly dissociated and added by heat, and has at least two peaks in each of curves of molecular weight distributions measured at 40° C. and 60° C. by gel permeation chromatography, wherein a change rate of the proportion of the area of the peak having the lowest molecular weight in measurement at 60° C. to the proportion of the area of the peak having the lowest molecular weight in measurement at 40° C.

Abstract: A polymerizable composition for optical components, which can prevent striae while keeping strength for optical components when a thick optical component is produced. A polymerizable composition for optical components is a mixture of a first composition including a polyisocyanate compound (A) and a second composition including a polythiol compound (B1) and a thiol group-containing substance (B2), the composition includes the thiol group-containing substance (B2) showing peak at a position at retention time three minutes or more from a peak of the polythiol compound (B1) in a chromatogram obtained by analyzing the composition by high performance liquid chromatography (HPLC) analysis, and the ratio (A/B1) is 80/100 to 95/100, wherein the equivalent ratio (A/B1) is an equivalent A of the polyisocyanate compound (A) using a weight and group number of the polyisocyanate compound (A) to B1 of the polythiol compound (B1) using a weight and group number of the polythiol compound (B1).

Abstract: Methods, compositions, and kits for adhering polymers and other materials to another material, and in particular to bone or bone-like structures or surfaces. A composition of matter includes a urethane dimethacrylate-methyl methacrylate copolymer with a plurality of first polymer regions based on urethane dimethacrylate and a plurality of second polymer regions based on methyl methacrylate. The method includes placing an orthopedic joint implant having an attachment surface in a joint space, applying a first non-urethane-containing precursor, a second urethane-containing precursor, and a initiator to the attachment surface; contacting the first and second precursors and the initiator with the joint surface; and copolymerizing the first and second precursors and forming an adhesive copolymer and attaching the implant to the joint.

Abstract: The present invention relates to rapid-curing resin formulations as well as fiber-reinforced composite materials comprising the same and their use in the manufacture of molded articles, particularly where the manufacturing process requires high throughput and where resin formulations having consistent handling characteristics (e.g., tack and flexibility) would be preferable across normal to elevated laminating environments (as defined by temperatures between 20° C. and 60° C.). The present invention further relates to a manufacturing process for preparing an article, particularly a molded article, from a fiber-reinforced composite material comprising a rapid-curing resin formulation.

Abstract: A curable resin composition containing: a curable resin; and a curing agent containing an imide oligomer, the imide oligomer containing an aliphatic diamine residue- and/or aliphatic triamine residue-containing imide oligomer that has, in a main chain, an imide skeleton and a substituted or unsubstituted aliphatic diamine residue having a carbon number of 4 or greater and/or a substituted or unsubstituted aliphatic triamine residue having a carbon number of 4 or greater, has a crosslinkable functional group at an end, and has a molecular weight of 5,000 or less. The curable resin composition is excellent in flexibility and processability before curing and excellent in adhesiveness, heat resistance, and dielectric characteristics after curing. An adhesive, an adhesive film, a circuit board, an interlayer insulating material, and a printed wiring board each produced using the curable resin composition are also provided.

Abstract: A biodegradable triblock copolymer comprising: an A-B-A? structure wherein the A and A? blocks each include polylactide, the B block includes from about 55 to about 100 mole percent of polytrimethylene carbonate and 0 to about 45 mole percent polylactide, and the biodegradable triblock copolymer overall includes from about 15 to about 25 mole percent of the polytrimethylene carbonate and from about 75 to about 85 mole percent of the polylactide. Also provided are compositions and implantable medical devices made therefrom.

Abstract: There is provided a cover for a millimeter-wave radar, the cover being provided on an antenna that transmits and/or receives a millimeter wave of 75 to 81 GHz, the cover containing a thermoplastic resin composition that contains an aromatic polycarbonate resin having a structural unit (A) represented by formula (1) below, the cover having a relative dielectric constant ?r of 3.0 or less, a dielectric loss tangent tan ? of 8.0×10?3 or less, and a loss factor ?r·tan ? of 17.0×10?3 or less: where in formula (1), R1 and R2 are each a hydrogen atom or a methyl group, and W1 is at least one selected from a single bond, an oxygen atom, a sulfur atom, and a divalent organic group.

Abstract: Provided is a block copolymer comprising a polymer block (A) formed from repeating units of formula (I): wherein R1 is methyl or ethyl, and a polymer block (B) formed from repeating units of formula (II): as well as a hydrogel comprising the block copolymer.

Abstract: The present invention discloses a class of nitrogen-containing heterocyclic polymers, a class of polymer membranes and applications thereof, wherein the nitrogen-containing heterocyclic polymers comprise structural units of following general formula: A nitrogen-containing heterocycles in the class of nitrogen-containing heterocyclic polymers have large steric hindrance and electron donating groups, which are beneficial for further improving stability of materials. The class of nitrogen-containing heterocyclic polymers can be formed membranes using commonly industrial methods such as coating.

Abstract: The present invention relates to a polyamic acid composition for packaging electronic components and a method for packaging electronic components using the same, wherein the polyamic acid composition comprises a dianhydride main component having a benzophenone structure as a dianhydride-based monomer in a high proportion and a diamine component having a benzene ring as a diamine-based monomer, whereby it is possible to improve a coefficient of thermal expansion, a glass transition temperature, an elongation, and the like of a polyimide thin film formed therefrom, and when the polyimide thin film is used as a packaging material for an inorganic material such as a silicon water, it exhibits excellent adhesion to the inorganic material and can be easily removed upon O2 plasma removal, as well as has a remarkably low residual ratio of organic residues on the surface of the inorganic material after the removal, so that it can be easily used as a packaging material for electronic components and the like.

Abstract: The present disclosure provides a modified allyl compound, and a modified bismaleimide prepolymer. The modified allyl compound is represented by formula (1), has a cyclopentadiene structure represented by formula (2), and contains a benzene ring or a benzene ring substituted with a linear alkane of lower polarity.

Abstract: A resin molded article having a microphase-separated structure, the resin molded article containing a polyimide resin (A) and a polyether ketone resin (B), the polyimide resin (A) containing repeating structural units of formulae (1) and (2): wherein R1 represents a divalent group having from 6 to 22 carbon atoms containing at least one alicyclic hydrocarbon structure; R2 represents a divalent chain aliphatic group having from 5 to 16 carbon atoms; and X1 and X2 each independently represent a tetravalent group having from 6 to 22 carbon atoms containing at least one aromatic ring, a content ratio of the repeating structural unit of formula (1) with respect to the total of the repeating structural unit of formula (1) and the repeating structural unit of formula (2) is 20 to 70 mol %, and a weight average molecular weight Mw is 40,000 to 150,000.

Abstract: A non- or low-boron putty base includes a crosslinked reaction product of at least one polydiorganosiloxane that has at least two reactive functional groups and at least one crosslinker capable of reacting with the reactive functional groups to form the crosslinked reaction product. The putty base is dilatant and may include 0 to 0.1 weight percent of a boron-containing compound. Dilatant putties made from the putty base and fillers are also provided. A method of making a dilatant putty includes: providing at least one polydiorganosiloxane including at least two reactive functional groups; providing an additive; providing at least one crosslinker capable of reacting with the reactive functional groups; and combining the polydiorganosiloxane, the filler, and the crosslinker to form the dilatant putty having less than 0.1 wt % boron.

Abstract: A silicone particle containing: a dialkylsiloxane unit represented by the following general formula (1), R42SiO2/2 (1), where, in the formula (1), R4s each independently represent a monovalent hydrocarbon group having 1 to 6 carbon atoms; and a poly(alkyleneoxyalkyl)methylsiloxane unit represented by the following general formula (2), where, in the formula (2), R1s each independently represent a hydrogen atom or a monovalent hydrocarbon group having 1 to 6 carbon atoms, R2s each independently represent a divalent aliphatic group having 1 to 6 carbon atoms, and “n” is a number that satisfies 1?n?20, where the silicone particle has an oxyalkylene group in a surface thereof. A silicone particle may be readily dispersed in an aqueous material without the use of a dispersant or a surfactant, the silicone particle having a hydrophilic group.

Abstract: The disclosure provides a nanodispersion of cellulose nanocrystals (CNCs) in monoethylene glycol (MEG) as well as a method for dispersing CNCs in MEG and a process for preparing a polymer composites comprising a CNC nanodispersion in MEG comprising copolymerizing said nanodispersion of CNCs and at least one monomer polymerizable with said MEG and/or CNCs.

Abstract: The invention relates to a method for creating a porous film through aqueous phase separation, the method comprising: i) providing an aqueous solution comprising a responsive copolymer, and optionally a charged polymer, wherein at least one of the monomers in the responsive copolymer is a responsive monomer; ii) forming the aqueous solution into a thin layer and contacting the thin layer of aqueous solution with an aqueous coagulation solution in which the responsive copolymer is not soluble, or contacting the thin layer of aqueous solution with an aqueous coagulation solution in which a complex comprising the responsive copolymer and the charged polymer is not soluble; and iii) allowing solvent exchange between the aqueous solution and the aqueous coagulation solution to produce a porous film. The invention further relates to porous films or membranes thus obtained.

Abstract: The present invention provides a layered product comprising a release layer that can be formed from an aqueous coating liquid, that is quickly released from the substrate when alkaline treatment is performed, and that has excellent water resistance. The layered product of the present invention is a layered product comprising a release layer on a substrate, the release layer comprising a granular carboxylic anhydride-modified olefin resin and a binding part containing an acid group-free thermoplastic resin, the carboxylic anhydride-modified olefin resin having an average particle size of 0.5 to 20 ?m, the binding part having a thickness of 0.25 to 20 ?m, and the release layer having an actual acid value of 100 mg KOH/m2 or more.

Abstract: A composition can be used for producing a PMMA-based cast polymer with a low styrene content using urea (derivatives) as a formulation constituent, and a hydrophilic inorganic compound as a filler. It is possible to produce PMMA-based cast polymers and mouldings having surprisingly high mechanical stability from the composition.

Abstract: Provided are: a resin additive composition containing a specific metal phosphate, which composition has excellent dispersibility in a resin even when made into a pellet form and exhibits a desired physical property improving effect when incorporated into a resin; and a synthetic resin composition using the same. The resin additive composition contains, with respect to 100 parts by mass of (A) sodium-2,2?-methylene-bis(4,6-di-tert-butylphenyl)phosphate: 25 to 400 parts by mass of (B) a lithium phosphate compound represented by the following Formula (1); and 10 to 300 parts by mass of (C) a fatty acid metal salt represented by the following Formula (2). The component (C) is incorporated in an amount of 10 parts by mass to 50 parts by mass with respect to a total of 100 parts by mass of the components (A) and (B).